← Leaderboards
Stephen M Prescott
University Of Utah
$8,122,610
Attributed
$8,122,610
Total exposure
13
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7M · FY2005–10$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$14,351,959 · 14
By mechanism
C06$7,030,924 · 1
P30$6,578,228 · 7
P50$495,220 · 2
R03$120,000 · 1
P01$100,568 · 1
M01$27,019 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Randall Walter Burt$9,014,360
- Martha Or Marty L Slattery$38,713,014
- James A. Disario$2,208,940
- Martin C Rechsteiner$4,032,271
- Dana Carroll$5,803,803
Others in their field
Top investigators on “Neoplasm /Cancer”
- Charles A Coltman · Southwest Oncology Group$175,115,529
- Gregory H Reaman · National Childhood Cancer Foundation$143,691,240
- Norman Wolmark · Nsabp Foundation, Inc.$129,902,100
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Bruce J Hillman · American College Of Radiology$89,322,170
- Richard L Schilsky · University Of Chicago$73,198,934
Research focus
Neoplasm /CancerBiomedical FacilityClinical ResearchLaboratory MouseGene ExpressionHuman SubjectEnzyme ActivityLung InjuryPhospholipidsCarboxylic Ester HydrolasesGenetically Modified AnimalsAdult Respiratory Distress SyndromeEnzyme MechanismTissue /Cell CultureVascular EndotheliumInflammationBrazilDisease /Disorder EtiologyDisease /Disorder ModelEnzyme StructureCell LineAcute Disease /DisorderColon PolypCatalyst
Grant awards (31)
Oklahoma Medical Research Foundation Clinical Research Construction$7,030,924
C06 · FY2010 · RR · contact PI
THE UTAH GENETIC REFERENCE PROJECT (UGRP)$926
M01 · FY2006 · RR · contact PI
Core--Informatics Facility$46,818
P30 · FY2005 · CA
Core--Microarray Facility$23,116
P30 · FY2005 · CA
Core--Nuclear Magnetic Resonance Facility$16,952
P30 · FY2005 · CA
THE UTAH GENETIC REFERENCE PROJECT (UGRP)$13,424
M01 · FY2005 · RR
Cancer Center Support Grant$743,089
P30 · FY2004 · CA
Developmental Funds$91,857
P30 · FY2004 · CA
Senior Leadership$59,029
P30 · FY2004 · CA
Cancer Center Support Grant$57,226
P30 · FY2004 · CA
Core--Informatics Facility$47,750
P30 · FY2004 · CA
Core--Microarray Facility$29,332
P30 · FY2004 · CA
Planning and Evaluation$17,568
P30 · FY2004 · CA
Core--Nuclear Magnetic Resonance Facility$16,457
P30 · FY2004 · CA
The Utah genetic reference project (UGRP)$12,669
M01 · FY2004 · RR
CANCER CENTER SUPPORT GRANT$1,408,260
P30 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$89,127
P30 · FY2003 · CA
Treating sepsis with PAF Acetylhydrolase$40,000
R03 · FY2003 · TW
CANCER CENTER SUPPORT GRANT$1,359,039
P30 · FY2002 · CA
REGULATION OF INFLAMMATORY LIPIDS IN ACUTE LUNG INJURY$245,455
P50 · FY2002 · HL
Treating sepsis with PAF Acetylhydrolase$40,000
R03 · FY2002 · TW
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS$0
P01 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$1,238,364
P30 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$190,643
P30 · FY2001 · CA
Treating sepsis with PAF Acetylhydrolase$40,000
R03 · FY2001 · TW
REGULATION OF INFLAMMATORY LIPIDS IN ACUTE LUNG INJURY$0
P50 · FY2001 · HL
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS$0
P01 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$1,143,601
P30 · FY2000 · CA
REGULATION OF INFLAMMATORY LIPIDS IN ACUTE LUNG INJURY$171,165
P50 · FY2000 · HL
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS$100,568
P01 · FY2000 · CA
ROLE OF BETA-2 INTEGRINS IN LEUKOCYTE ADHESION AND SIGNALING$78,600
P50 · FY2000 · DK